Skip to content

Innofluidics Diagnostics

Active
Private limited companyfounded 20242 yrs activeAgoralaan Gebouw A, 3590 Diepenbeek, BelgiumKBO/BCE: BE 1007.747.747
Summary

Innofluidics Diagnostics has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,187 and a net result of €687. Its solvency ranks better than 16% of 527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Checked score

Score 2025
Axes
Profitability70
Solvency29
Growth-
Track record67
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 527 sector peers (2025).
NBB · sector comparison
Position among 527 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
4 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 28 March 2024, Innofluidics Diagnostics was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€3,187
Total assets
€85,517
Net result
€687
Working capital
-€59,894

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €81,450
Fixed assets €59,014
Current assets €22,436
Equity and liabilities €85,517
Equity €3,187
Debt €82,330
Debt finances 96.3% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€23,789
Cash flow
€22,803
Current ratio
0.27
Debt to equity
25.83
ROE
21.6%
ROA
0.8%
Interest coverage
172.21
Debt ≤ 1 year
€82,330
Income taxes
€848
Staff costs
€171,043

Peer companies

Historical observation

Of the 2,135 companies that looked in July 2024 the way this one looks now, 5.2% went bankrupt within 24 months and 92% are still going.

  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit under 5% of the balance sheet
5.2% went bankrupt
2.3% stopped otherwise
92% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 1.0% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,135 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 38 lines
Balance sheet Code2025
Assets
Total assets20/58€85,517
Formation expenses20€4,067
Fixed assets21/28€59,014
Intangible fixed assets21€48,670
Financial fixed assets28€10,344
Current assets29/58€22,436
Amounts receivable within one year40/41€13,622
Trade receivables40€10,155
Other amounts receivable41€3,467
Cash at bank and in hand54/58€7,824
Deferred charges and accrued income490/1€990
Equity and liabilities
Total equity and liabilities10/49€85,517
Equity10/15€3,187
Contributions10/11€2,500
Reserves13€687
Distributable reserves133€687
Amounts payable17/49€82,330
Amounts payable within one year42/48€82,330
Trade debts44€9,649
Suppliers440/4€9,649
Taxes, remuneration and social security45€21,731
Taxes450/3€1,314
Remuneration and social security454/9€20,417
Other amounts payable47/48€50,950
Income statement Code2025
Remuneration, social security and pensions62€171,043
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22,116
Other operating charges640/8€663
Gross operating margin9900€195,494
Operating profit (loss)9901€1,673
Financial charges65/66B€138
Recurring financial charges65€138
Profit (loss) for the period before taxes9903€1,535
Income taxes67/77€848
Profit (loss) for the period9904€687
Profit (loss) for the period to be appropriated9905€687
Appropriation of the result
Profit (loss) to be appropriated9906€687
Transfer to equity691/2€687
To other reserves6921€687

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€171,043
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22,116
Other operating charges640/8€663
Gross operating margin9900€195,494
Operating profit (loss)9901€1,673
Financial charges65/66B€138
Recurring financial charges65€138
Profit (loss) for the period before taxes9903€1,535
Income taxes67/77€848
Profit (loss) for the period9904€687
Profit (loss) for the period to be appropriated9905€687
Line2025
Assets
Total assets20/58€85,517
Formation expenses20€4,067
Fixed assets21/28€59,014
Intangible fixed assets21€48,670
Financial fixed assets28€10,344
Current assets29/58€22,436
Amounts receivable within one year40/41€13,622
Trade receivables40€10,155
Other amounts receivable41€3,467
Cash at bank and in hand54/58€7,824
Deferred charges and accrued income490/1€990
Equity and liabilities
Total equity and liabilities10/49€85,517
Equity10/15€3,187
Contributions10/11€2,500
Reserves13€687
Distributable reserves133€687
Amounts payable17/49€82,330
Amounts payable within one year42/48€82,330
Trade debts44€9,649
Suppliers440/4€9,649
Taxes, remuneration and social security45€21,731
Taxes450/3€1,314
Remuneration and social security454/9€20,417
Other amounts payable47/48€50,950
Line2025
Profit (loss) for the period9904€687
+ Depreciation and write-downs630€22,116
Operating cash flow (approximation)€22,803

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 1 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Diepenbeek · 1 establishment unit since 2024
seat establishment approximate The establishment unit on the map
Ground area
2.5 ha
Parcel 71011A0272/00F000, Flanders. Linked by address, not a title deed.
1 establishment unit
Innofluidics Diagnostics
Agoralaan Gebouw Abi, 3590 DiepenbeekComputing infrastructure, data processing, hosting and related activities
since 20242.358.078.611
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71011A0272/00F000 Flanders 2.5 ha - -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 762 companies in this sector we hold annual accounts for 484. 66 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded28-03-2024
Fiscal year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
72101Research and development on biotechnology
63920Other information service activities
74999Other professional, scientific and technical activities
E-invoicing
Reachable via Peppol
Peppol ID 0208:1007747747
Also 9925:BE1007747747
Registered 07-10-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.